Clinical Trial Update: A Study to Determine Effective Prophylaxis and Treatment of Nelfinavir-Associated Diarrhea [Phase 3]

View source ↗

Summary

Pfizer's Phase 3 trial evaluating prophylaxis and treatment of nelfinavir-associated diarrhea has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea

Drugs mentioned

• Nelfinavir (nelfinavir)

Snippet

Sponsor: Pfizer | Conditions: Diarrhea | Phase 3 | Status: TERMINATED